Peripheral Lewy body pathology in Parkinson's disease and incidental Lewy body disease: Four cases
Introduction
In 1912, Fritz Jacob Lewy described protein aggregates in the brains of patients with Parkinson's disease (PD) in several areas of the brain, including the dorsal vagal nucleus, locus coeruleus, and globus pallidus [1]. Some years later, Konstantin Trétiakoff named them Lewy bodies (LBs) and described them in the substantia nigra [2]. The substantia nigra was the focus of most neuropathological studies in PD until recently, when it was proposed that the pathological hallmarks of PD begin in the lower brainstem and in the olfactory system [3], [4], [5], [6]. These and other studies have highlighted the importance of pathology in the autonomic nervous system as an early induction site for the pathological progression of Lewy pathology (comprised of LBs and Lewy neurites, LNs) through the neuraxis [7], [8], [9], [10]. Newer studies of patients with PD have revealed that most have symptoms of autonomic dysfunction [11], [12] that are often the presenting symptom and are strongly correlated with quality of life [13], [14], [15].
In an effort to develop better ways to diagnose PD before patients lose sufficient nigrostriatal function to manifest the typical PD-related motor symptoms, there has been a greater emphasis on defining the autonomic dysfunction that occurs at the earliest stages of disease development. The focus has also shifted to the analysis of patients without motor PD in whom LP are found at autopsy, i.e., incidental Lewy body disease (ILBD) [5], [16], [17], [18], [19], [20], [21]. In this study, we report on the presence of LP in the autonomic nervous system of three PD cases and one ILBD case using alpha-synuclein immunohistochemistry in 100 μm thick tissue sections to visualize the morphology of LP.
Section snippets
Materials and methods
Consent for autopsy was obtained for all four patients, and the study was performed in compliance with university ethics committee guidelines and the laws governing human tissue usage in the German federal state of Baden–Württemberg. Tissue samples obtained from the brains and peripheral organs of three females with clinically and neuropathologically confirmed PD (ages 68, 71 and 86; mean disease duration ± SD: 14 ± 2.65 years) and one asymptomatic male (65 years of age) with neuropathologically
Case 1
Incidental peripheral LP observed in a 65-year-old male who died of acute myocardial infarction shortly after retirement. He had a history of coronary artery disease, hypertension, hypertriglyceridemia, and hypercholesterolemia. There was no known history of neurological disease or motor symptoms associated with a movement disorder, and his activities of daily living (ADLs) were intact. His medical records noted the presence of gastrointestinal symptoms, primarily indigestion. Autopsy findings
Discussion
The presence of LP in the autonomic nervous system has been recognized for more than 50 years [33]. However, recent attempts to define precisely where the accumulation of LP commences in the nervous system have drawn increased attention to these lesions. It is plausible that LP accumulation might begin within the autonomic nervous system, e.g., in axons of enteric nervous system neurons. Here, we also reported on a case of ILBD with involvement of enteric nervous system intramural fibers [29],
Acknowledgments
This study was made possible by funding from the German Research Council (DFG) grant number TR 1000/1-1, the Michael J. Fox Foundation for Parkinson's Disease Research (New York City, USA) (KDT), and a Merit Award from the Biomedical Laboratory Research Service of the Department of Veterans Affairs, USA (JED). The authors also thank Heiko Braak, M.D. (University of Ulm) for his comments and Ellen Gelpi, M.D. (Institut de Neuropatologia, Hospital Universitari de Bellvitge, Barcelona, Spain) for
References (48)
- et al.
Staging of brain pathology related to sporadic Parkinson's disease
Neurobiol Aging
(2003) - et al.
Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria
Lancet Neurol
(2009) - et al.
Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology
Neurosci Lett
(2006) - et al.
Esophageal Lewy bodies associated with ganglion cell loss in achalasia. Similarity to Parkinson's disease
Gastroenterology
(1984) Olfactory system pathology as a model of Lewy neurodegenerative disease
J Neurol Sci
(2010)- et al.
Lewy-body formation is an aggresome-related process: a hypothesis
Lancet Neurol
(2004) - et al.
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein
Neuron
(2002) Do disorders of movement cause movement disorders and dementia?
Neuron
(2003)Paralysis agitans. Part I: Pathologische anatomie
Contribution a l'etude de l'anatomie pathologique du locus niger de Soemmering avec quelques deductions relatives a la pathogenie des troubles du tonus musculaire et de la maladie de Parkinson
(1919)
Where does Parkinson disease pathology begin in the brain?
J Neuropathol Exp Neurol
Idiopathic Parkinson's disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen
J Neural Transm
Neuroanatomy and pathology of sporadic Parkinson's disease
Adv Anat Embryol Cell Biol
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease
Acta Neuropathol
Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease
Mov Disord
Parkinson's disease with involvement of the parasympathetic ganglia
Acta Neuropathol
Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses
Acta Neuropathol
Prevalence of nonmotor symptoms in Parkinson's disease in an international setting; study using nonmotor symptoms questionnaire in 545 patients
Mov Disord
The PRIAMO study: a multicenter assessment of non motor symptoms and their impact on quality of life in Parkinson's disease
Mov Disord
Patient-reported autonomic symptoms in Parkinson disease
Neurology
What are the most important nonmotor symptoms in patients with Parkinson's disease and are we missing them?
Mov Disord
The impact of non-motor symptoms on health-related quality of life of patients with Parkinson's disease
Mov Disord
Lewy body-type degeneration in cardiac plexus in Parkinson's and incidental Lewy body diseases
Neurology
Alpha-synuclein pathology of the spinal and peripheral autonomic nervous system in neurologically unimpaired elderly subjects
Neuropathol Appl Neurobiol
Cited by (26)
Alpha-synuclein in skin as a high-quality biomarker for Parkinson's disease
2023, Journal of the Neurological SciencesMIBG myocardial scintigraphy in pre-motor Parkinson's disease: Areview
2014, Parkinsonism and Related DisordersCitation Excerpt :It is now acknowledged that DLB may produce a wide spectrum of clinical symptoms, including dementia and spontaneous parkinsonism (the core clinical features), together with depression, sleep disorder, and autonomic disorder [24]. Regarding LB pathology, approximately 8–17% of neurologically normal subjects over 60 years of age have LB on postmortem examination, referred to as incidental LBD [25]. Some pathology-proven LBD patients have shown amnestic MCI before progressing to the core clinical features of DLB (dementia and spontaneous parkinsonism) [26].
Skin nerve phosphorylated a-synuclein in the elderly
2024, Journal of Neuropathology and Experimental NeurologyNeuropathology of incidental Lewy body & prodromal Parkinson’s disease
2023, Molecular Neurodegeneration